Results for deksmedetomidin translation from Slovenian to English

deksmedetomidin
dexmedetomidine

deksmedetomidin deksmedetomidin
dexmedetomidine dexmedetomidine

deksmedetomidin 125 mikrogramov/m2
dexmedetomidine 125 micrograms/m2

zdravilna učinkovina je deksmedetomidin.
the active substance is dexmedetomidine.

deksmedetomidin je sedativ in uspavalo.
dexmedetomidine is a sedative and sleep inducing drug.

deksmedetomidin 40 mikrogramov/kg intramuskularno
dexmedetomidine 40 micrograms/kg intramuscularly

deksmedetomidin je agonist alfa2-adrenoreceptorja.
dexmedetomidine is an alpha2-adrenoceptor agonist.

deksmedetomidin je 94 % vezan na plazemske beljakovine.
dexmedetomidine is 94% bound to plasma proteins.

deksmedetomidin se izloča z obsežno presnovo v jetrih.
dexmedetomidine is eliminated by extensive metabolism in the liver.

dexdor je zdravilo, ki vsebuje zdravilno učinkovino deksmedetomidin.
dexdor is a medicine that contains the active substance dexmedetomidine.

deksmedetomidin se kot lipofilna spojina po intramuskularnem dajanju dobro absorbira.
as a lipophilic compound, dexmedetomidine is well absorbed after intramuscular administration.

deksmedetomidin 125 mikrogramov/m2 (mikrogra (ml) mov/kg)
dexmedetomidine 125 mcg/m2 (mcg/kg) (ml)

deksmedetomidin je združljiv z butorfanolom in ketaminom v isti brizgi najmanj dve uri.
dexmedetomidine is compatible with butorphanol and ketamine in the same syringe at least for two hours.

zdravilna učinkovina zdravila dexdomitor, deksmedetomidin, je agonist α2 - adrenoreceptorja.
the active substance in dexdomitor, dexmedetomidine, is an alpha2-adrenoceptor agonist.

deksmedetomidin je zelo močno zdravilo, zato je njegova hitrost infundiranja podana na uro.
dexmedetomidine is very potent and the infusion rate is given per hour.

deksmedetomidin je selektiven agonist receptorjev alfa-2 s širokim razponom farmakoloških lastnosti.
dexmedetomidine is a selective alpha-2 receptor agonist with a broad range of pharmacological properties.

deksmedetomidin zaradi α2-adrenergičnega delovanja povzroča zmanjšanje srčnega utripa in telesne temperature.
by virtue of its α2-adrenergic activity, dexmedetomidine causes a decrease in heart rate and body temperature.

deksmedetomidin se presnovi v jetrih, zato ga je treba pri bolnikih z jetrno okvaro uporabljati previdno.
dexmedetomidine is metabolised in the liver and should be used with caution in patients with hepatic impairment.

v klinični študiji je deksmedetomidin prispeval k pooperativni analgeziji, ki je trajala 0,5–4 ure.
in a clinical study, dexmedetomidine contributed to postoperative analgesia for 0.5 – 4 hours.

deksmedetomidin je močan in selektiven agonist α2-adrenoreceptorjev, ki zavira sproščanje noradrenalina iz noradrenergičnih nevronov.
dexmedetomidine is a potent and selective α2-adrenoceptor agonist that inhibits the release of noradrenaline from noradrenergic neurons.